Acquired Aplastic Anaemia

Postgraduate Haematology: Sixth Edition

Volumn , Issue , 2010, Pages 206-225

  Marsh, Judith CW ^a   Young, Neal S ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Antithymocyte globulin; Aplastic anaemia; ATG; Bone marrow failure; Clonal evolution; Cyclosporin; Immunosuppressive therapy; Paroxysmal nocturnal haemoglobinuria; PNH; Telomerase gene

Indexed keywords

EID: 84859457898     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444323160.ch13     Document Type: Chapter

References (56)

1. Bacigalupo A (2007) Aplastic anaemia: pathogenesis and treatment. Hematology. American Society of Hematology Education Program, 23-8.
2. Bacigalupo A, Brand R, Oneto R et al. (2000) Treatment of acquired severe aplastic anaemia: bone marrow transplantation compared with immunosuppressive therapy. The European Group for Blood and Marrow Transplantation experience. Seminars in Hematology 37: 69-80.
3. Bacigalupo A, Bruno B, Saracco P et al. (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 95: 1931-4.
4. Bacigalupo A, Locatelli F, Lanino E et al. (2005) Fludarabine, cyclophosphamide and ATG for alternative donor transplants in acquired severe aplastic anaemia: a report of the EBMT SAA Working Party. Bone Marrow Transplantation 41: 45-50.
5. Bacigalupo A, Locatelli F, Lanino E et al. (2009) Fludarabine, cyclophosphamide with or without low dose TBI for alternative donor transplants in acquired aplastic anemia (SAA): a report from the EBMT-SAA Working Party. Biology of Blood and Marrow Transplantation 15: 5.
6. Bennett JM, Orazi A (2009) Diagnostic criteria to distinguish hypocellular acute myeloid leukaemia from hypocellular myelodysplastic syndromes and aplastic anaemia: recommendations for a standardized approach. Haematologica 94: 264-8.
7. Buyck HC, Ball S, Junagade P, Marsh J, Chakrabarti S (2009) Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia. Bone Marrow Transplantation 43: 813-16.
8. Calado RT, Young NS (2008) Telomere maintenance and human bone marrow failure. Blood 111: 4446-55.
9. Calado RT, Graf SA, Wilkerson KL et al. (2007) Mutations in the SBDS gene in acquired aplastic anaemia. Blood 110: 1141-6.
10. Camitta BM, Rappeport JM, Parkman R, Nathan DG (1975) Selection of patients for bone marrow transplantation in severe aplastic anaemia. Blood 45: 355-63.
11. Champlin RE, Perez WS, Passweg J et al. (2007) Bone marrow transplantation for severe aplastic anaemia: a randomized controlled study of conditioning regimens. Blood 109: 4582-5.
12. Cooper JN, Calado R, Wu C et al. (2008) Telomere length of peripheral blood leucocytes predicts relapse and clonal evolution after immunosuppressive therapy in severe aplastic anaemia [Abstract]. Blood 112, 442.
13. Deeg HJ, O'Donnell M, Tolar J et al. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anaemia after failure of immunosuppressive therapy. Blood 108: 1485-91.
14. + regulatory T cells in vitro. Blood 111: 3675-83.
15. Frickhofen N, Heimpel H, Kaltwasser JP et al. (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anaemia. Blood 101: 1236-42.
16. Gupta V, Ball S, Yi Q et al. (2004) Favourable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia. Biology of Blood and Marrow Transplantation 7, 867-76.
17. Gupta V, Brooker C, Tooze J et al. (2006) Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. British Journal of Haematology 134: 95-9.
18. +cell dose on clinical and haematological outcome after allo-HSCT for acquired aplastic anaemia. Bone Marrow Transplantation. doi: 10.1038/bmt.2009.267.
19. Issaragrisil S, Kaufman D, Anderson T and the Aplastic Anaemia Study Group (2006) The epidemiology of aplastic anaemia in Thailand. Blood 107: 1299-307.
20. Kao SY, Xu W, Brandwein JM et al. (2008) Outcomes of older patients (≥ 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy. British Journal of Haematology 143: 738-43.
21. Kojima S, Hibi S, Kosaka Y et al. (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96: 2049-54.
22. Kojima S, Matsuyama T, Kato S et al. (2002) Outcome of 154 patients with severe aplastic anaemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100: 799-803.
23. Kosaka Y, Yagasaki H, Sano K et al. (2008) Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anaemia. Blood 111: 1054-9.
24. Landgren O, Gilbert OS, Rizzo JD et al. (2009) Risk factors for lymphoproliferative disorders after allogeneic haematopoietic cell transplantation. Blood 113: 4992-5001.
25. Locasciulli A, Oneto R, Bacigalupo A et al. (2007) Outcome of patients with acquired aplastic anaemia given first line bone marrow transplantation or immunosuppression treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 91: 11-18.
26. McCann S, Passweg J, Bacigalupo A et al. (2007) The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplantation 39: 109-14.
27. Mao P, Zhu Z, Wang H et al. (2005) Sustained and stable haematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anaemia. European Journal of Haematology 75: 430-5.
28. Marsh JCW, Testa NG (2000) Stem cell defect in aplastic anaemia. In: Aplastic Anaemia. Pathophysiology and Treatment (H Schrezenmeier, A Bacigalupo, eds), pp. 3-20. Cambridge University Press, Cambridge.
29. Marsh JC, Ball SE, Darbyshire P et al. (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. British Journal of Haematology 123: 782-801. (The 2008 revised guidelines are available at www.bschguidelines.org.uk)
30. Marsh JCW, Ganser A, Stadler M (2007) Haematopoietic growth factors in the treatment of acquired bone marrow failure states. Seminars in Hematology 44: 138-47.
31. Marsh JCW, Ball SE, Cavenagh J et al. (2009) Guidelines for the diagnosis and management of aplastic anemia. British Journal of Haematology 147: 43-70.
32. Maury S, Balère-Appert M-L, Chir Z et al. (2007) Unrelated stem cell transplantation for severe acquired aplastic anaemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 92: 589-96.
33. Montané E, Ibáñez L, Vidal X et al. (2008) Epidemiology of aplastic anaemia: a prospective multicenter study. Haematologica 93: 518-23.
34. Myers KC, Davies SM (2009) Haemopoietic stem cell transplantation for bone marrow failure syndromes in children. Biology of Blood and Marrow Transplantation 15: 279-92.
35. Risitano A, Maciejewski J, Green S et al. (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR b-CDR3 sequencing. Lancet 364: 355-64.
36. Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anaemia: association between hematologic response and long-term outcome. Journal of the American Medical Association 289: 1130-5.
37. Saracco P, Quarello P, Iori AP et al. (2008) Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. British Journal of Haematology 140: 197-205.
38. Scheinberg P, Nunez O, Wu C, Young NS (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal of Haematology 133: 606-11.
39. Scheinberg P, Wu CO, Nunez O, Young NS (2008) Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. Journal of Pediatrics 153: 814-19.
40. Scheinberg P, Wu CO, Nunez O, Young NS (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. British Journal of Haematology 144: 206-16.
41. Scheinberg P, Wu CO, Nunez O et al. (2009) Treatment of severe aplastic anaemia with a combination of horse antithymocyte and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 94: 348-54.
42. Schrezenmeier H, Passweg JR, Marsh JCW et al. (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anaemia. Blood 110: 1397-400.
43. Siegal D, Xu W, Sutherland R et al. (2008) Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplantation 42: 51-6.
44. Sloand EM, Yong ASM, Ramkissoon S et al. (2006) Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proceedings of the National Academy of Sciences USA 103: 14483-8.
45. Socie G, Henry-Amar M, Bacigalupo A et al. (1993) Malignant tumours occurring after treatment of aplastic anaemia. New England Journal of Medicine 329: 1152-7.
46. Socie G, Rosenfeld S, Frickhofen N et al. (2000) Late clonal diseases of treated aplastic anaemia. Seminars in Hematology 37: 91-100.
47. Socie G, Mary J-Y, Schrezenmeier H et al. (2007) Granulocyte colony stimulating factor for severe aplastic anaemia: a survey by the European Group for Blood and Marrow Transplantation. Blood 109: 2794-6.
48. + T regulatory cells in acquired aplastic anaemia. Blood 110: 1603-6.
49. Sugimori C, Chuhjo T, Feng X et al. (2005) Minor populations of CD55-CD59-blood cells predict response to immunosuppressive therapy and prognosis in patients with aplastic anaemia. Blood 107: 1308-14.
50. Teramura M, Kimura A, Iwasse S et al. (2007) Treatment of severe aplastic anaemia with antithymocyte globulin and cyclosporine A with or without G-CSF in adults: a multicentre randomized study in Japan. Blood 110: 1756-61.
51. Tisdale JF, Dunn DE, Geller N et al. (2000) High dose cyclophosphamide in severe aplastic anaemia: a randomized trial. Lancet 356: 1554-7.
52. Viollier R, Socie G, Tichelli A et al. (2007) Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplantation 41: 45-50.
53. Walne AJ, Dokal I (2009) Advances in the understanding of dyskeratosis congenita. British Journal of Haematology 145: 164-72.
54. Yamaguchi H, Calado R, Ly H et al. (2005) Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anaemia. New England Journal of Medicine 352: 1413-24.
55. Yoshimi A, Kojima S, Taniguchi S et al. (2008) Unrelated cord blood transplantation for severe aplastic anemia. Biology of Blood and Marrow Transplantation 14: 1057-63.
56. Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anaemia. Blood 108: 2509-19.